Misty M. Miller, Pharm. D., BCPS

Associate Professor of Pharmacy
Adjunct Associate Professor of Medicine

1110 N. Stonewall
CPB-231
Oklahoma City, OK 73104

405-271-6878 x47029

Academic Section(s):

Infectious Diseases

Education:

Doctor of Pharmacy, 2009
University of Oklahoma Health Sciences Center
Oklahoma City, OK

Residency:

Pediatric Pharmacy Resident, 2011
University of Oklahoma Heath Sciences Center
Oklahoma City, OK

Pharmacy Residency, 2010
University of Oklahoma Health Sciences Center
Oklahoma City, OK

Clinical/Research Interests:

Adult and pediatric HIV, HCV

Select Publications:

Badowski ME, Britt N, Huesgen, Lewis MM, Miller MM, Nowak K, Sherman E, Smith RO. Pharmacotherapy considerations in transgender individuals living with Human Immunodeficiency Virus (HIV). Pharmacotherapy 2021;41(3):299-314.

Kilcrease C, Miller MM, Neely S, Liedtke MD. Pharmacist impact on the HIV care continuum: decreasing time to care. J Am Coll Clin Pharm 2020;3(3):586-92.

Miller MM. Velpatasvir/sofosbuvir: a single-tablet treatment for hepatitis C infection of all genotypes. Am J Health-Syst Pharm 2017;74(14):1042-52.

Miller MM, Kinney KK, Liedtke ML. Virologic failure of high-dose raltegravir with concomitant rifampin. Infect Dis Clin Pract 2017;25:168-70.

Miller MM, Liedtke MD, Lockhart SM, Rathbun RC. The role of dolutegravir in the management of HIV infection. Infect Drug Resist 2015;8:19-29.